JP2011502964A5 - - Google Patents

Download PDF

Info

Publication number
JP2011502964A5
JP2011502964A5 JP2010531040A JP2010531040A JP2011502964A5 JP 2011502964 A5 JP2011502964 A5 JP 2011502964A5 JP 2010531040 A JP2010531040 A JP 2010531040A JP 2010531040 A JP2010531040 A JP 2010531040A JP 2011502964 A5 JP2011502964 A5 JP 2011502964A5
Authority
JP
Japan
Prior art keywords
subject
peptide
clip
treating
clip inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010531040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502964A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/012078 external-priority patent/WO2009055005A2/en
Publication of JP2011502964A publication Critical patent/JP2011502964A/ja
Publication of JP2011502964A5 publication Critical patent/JP2011502964A5/ja
Pending legal-status Critical Current

Links

JP2010531040A 2007-10-23 2008-10-23 インバリアント鎖発現および／または異所性ｃｌｉｐ結合の競合的阻害剤 Pending JP2011502964A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15207P 2007-10-23 2007-10-23
US13715008P 2008-07-25 2008-07-25
US13596408P 2008-07-25 2008-07-25
PCT/US2008/012078 WO2009055005A2 (en) 2007-10-23 2008-10-23 Competitive inhibitors of invariant chain expression and/or ectopic clip binding

Publications (2)

Publication Number Publication Date
JP2011502964A JP2011502964A (ja) 2011-01-27
JP2011502964A5 true JP2011502964A5 (OSRAM) 2012-12-20

Family

ID=40580294

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010531040A Pending JP2011502964A (ja) 2007-10-23 2008-10-23 インバリアント鎖発現および／または異所性ｃｌｉｐ結合の競合的阻害剤

Country Status (6)

Country Link
US (4) US8957031B2 (OSRAM)
EP (1) EP2215108A4 (OSRAM)
JP (1) JP2011502964A (OSRAM)
AU (1) AU2008317374B2 (OSRAM)
CA (1) CA2703585A1 (OSRAM)
WO (1) WO2009055005A2 (OSRAM)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2117558A4 (en) * 2007-01-26 2013-04-03 Univ Colorado METHOD FOR MODULATING THE IMMUNO FUNCTION
EP2215108A4 (en) * 2007-10-23 2012-07-04 Univ Colorado COMPETITIVE INHIBITORS OF THE EXPRESSION OF THE CONSTANT CHAIN AND / OR THE ECTOPIC CLIP BINDING
CA2737146A1 (en) * 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Clip inhibitors and methods of modulating immune function
US20100166782A1 (en) * 2008-07-25 2010-07-01 Martha Karen Newell Clip inhibitors and methods of modulating immune function
WO2010011315A2 (en) * 2008-07-25 2010-01-28 Viral Genetics, Inc. Proteins for use in diagnosing and treating infection and disease
WO2012094495A2 (en) 2011-01-05 2012-07-12 The Texas A&M University System Clip modulation for the treatment of mucosal diseases
WO2012138708A1 (en) * 2011-04-04 2012-10-11 The Texas A&M University System Mhc engagement and clip modulation for the treatment of disease
CA2862491A1 (en) 2011-12-01 2013-06-06 Scott & White Healthcare Methods and products for treating preeclampsia and modulating blood pressure
WO2015035414A1 (en) * 2013-09-09 2015-03-12 The Texas A&M University System Treating neurological disorders
GB2536650A (en) 2015-03-24 2016-09-28 Augmedics Ltd Method and system for combining video-based and optic-based augmented reality in a near eye display
US20170177802A1 (en) * 2015-12-17 2017-06-22 Allergy Solutions, Inc. Allergy Service Management Portal
HRP20210698T1 (hr) 2015-12-22 2021-09-17 Immatics Biotechnologies Gmbh Peptidi i kombinacija peptida za uporabu u imunoterapiji protiv karcinoma dojke i drugih karcinoma
GB201522667D0 (en) * 2015-12-22 2016-02-03 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
WO2019055860A1 (en) * 2017-09-15 2019-03-21 The Texas A&M University System METHODS FOR IMPROVING IMMUNOTHERAPY IN THE TREATMENT OF CANCER
US12458411B2 (en) 2017-12-07 2025-11-04 Augmedics Ltd. Spinous process clamp
EP3517117A1 (en) * 2018-01-30 2019-07-31 Medizinische Universität Wien Medicament for prevention or treatment of rhinovirus infection
WO2019211741A1 (en) 2018-05-02 2019-11-07 Augmedics Ltd. Registration of a fiducial marker for an augmented reality system
US11766296B2 (en) 2018-11-26 2023-09-26 Augmedics Ltd. Tracking system for image-guided surgery
CN110033822B (zh) * 2019-03-29 2020-12-08 华中科技大学 蛋白质编码方法及蛋白质翻译后修饰位点预测方法及系统
TWI747121B (zh) * 2019-05-21 2021-11-21 大江生醫股份有限公司 茶樹葉的發酵物用於調控ＣＣＴ基因、Ｐｉｎｋ１基因、ＰＡＲＰ２基因、ＭＩＴＦ基因、ＵＮＧ基因、ＥＲＣＣ６基因、ＴＥＲＣ基因、ＣＤ４０基因、ＤＹＮＬＬ２基因、ＧＲＫ５基因、ＲＥＬＢ基因、ＴＮＦＳＦ１４基因、ＩＬ４Ｒ基因與ＲＥＬＡ基因的表現量及抗老化、美白、提升免疫力與降低脂肪累積之用途
CN110296833B (zh) * 2019-07-22 2020-08-18 齐鲁工业大学 一种面向液压缸综合测试台的软测量方法及系统
US11980506B2 (en) 2019-07-29 2024-05-14 Augmedics Ltd. Fiducial marker
US12178666B2 (en) 2019-07-29 2024-12-31 Augmedics Ltd. Fiducial marker
US11382712B2 (en) 2019-12-22 2022-07-12 Augmedics Ltd. Mirroring in image guided surgery
KR20230074065A (ko) * 2020-05-22 2023-05-26 카를로스 알베르토 리베로스 기도 점막에서 바이러스 복제를 감소시키기 위한 특정 약물 시스템, 방법 및 용도
US11389252B2 (en) 2020-06-15 2022-07-19 Augmedics Ltd. Rotating marker for image guided surgery
US12239385B2 (en) 2020-09-09 2025-03-04 Augmedics Ltd. Universal tool adapter
US20220293228A1 (en) * 2021-03-09 2022-09-15 Glenn Loomis Identification of Allergens in Food Products
US11896445B2 (en) 2021-07-07 2024-02-13 Augmedics Ltd. Iliac pin and adapter
US12150821B2 (en) 2021-07-29 2024-11-26 Augmedics Ltd. Rotating marker and adapter for image-guided surgery
US12475662B2 (en) 2021-08-18 2025-11-18 Augmedics Ltd. Stereoscopic display and digital loupe for augmented-reality near-eye display
EP4511809A1 (en) 2022-04-21 2025-02-26 Augmedics Ltd. Systems and methods for medical image visualization
IL319523A (en) 2022-09-13 2025-05-01 Augmedics Ltd Augmented reality glasses for image-guided medical intervention

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
JPH075476B2 (ja) 1984-01-12 1995-01-25 ルッシュ、フォルケル ホルモン活性を有する生物学的作用物質、その製法およびヒストンの医薬的用途
DE3546806C2 (OSRAM) 1985-03-30 1991-03-28 Marc Genf/Geneve Ch Ballivet
US7252829B1 (en) 1998-06-17 2007-08-07 Idm Pharma, Inc. HLA binding peptides and their uses
AU3916093A (en) 1992-03-13 1993-10-05 Terry R. Beardsley Immune-enhancing agent for therapeutic use in immunocompromised hosts
US20050271676A1 (en) 1993-03-05 2005-12-08 Epimmune Inc. Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions
US5756666A (en) 1993-10-19 1998-05-26 Ajinomoto Co., Inc. Peptides capable of inducing immune response to HIV
US7625565B2 (en) 1995-05-01 2009-12-01 Viral Genetics, Inc. Antiviral compositions comprising lysine-rich histone fractions prepared by pepsin treatment of thymic cell nuclei
BR9608837A (pt) 1995-05-01 1999-12-07 Tomson U S A Ltd "composição obtida de células para detectar uma infecção por vìrus da imunodeficiência humana, aparelho, kit e métodos para sua detecção, purificação da proteìna e sua obtenção e tratamento do ser humano"
AU7690896A (en) 1995-09-14 1997-04-01 Universitat Tubingen Recombinant polypeptide based on the primary sequence of the invariant chain with at least one primary sequence of a specific t-cell epitope or a protein derivative and nucleic acids coding for this recombinant polypeptide
AU1087797A (en) * 1996-01-03 1997-08-01 Australian National University, The Clip analogues and autoimmune disease
US20060008448A1 (en) * 1996-06-11 2006-01-12 Minzhen Xu Inhibition of li expression in mammalian cells
CA2270223A1 (en) 1996-10-28 1998-05-07 Carson B. Burgstiner (Deceased) Methods and compositions for dietary supplementation
WO1998037178A1 (en) 1997-02-24 1998-08-27 The Johns Hopkins University Immunomodulatory polypeptides derived from the invariant chain of mhc class ii
MY131805A (en) * 1997-09-18 2007-09-28 Biogen Idec Inc Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis.
US6165493A (en) 1997-10-22 2000-12-26 New York Blood Center, Inc. "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US20020182222A1 (en) 1998-07-10 2002-12-05 Groot Anne De HIV vaccine candidate peptides
US6734192B1 (en) * 1999-08-23 2004-05-11 Mp-1 Inc. Treatment of viral infections
US20020164685A1 (en) 2000-01-31 2002-11-07 Rosen Craig A. Nucleic acids, proteins, and antibodies
WO2002061087A2 (en) * 2000-12-19 2002-08-08 Lifespan Biosciences, Inc. Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides
JP2005500336A (ja) 2001-07-25 2005-01-06 ニューヨーク・ユニバーシティ 感染および癌に対するワクチンのためのアジュバントとしてのグリコシルセラミドの使用
CN1458165A (zh) 2002-01-26 2003-11-26 北海新升技术开发有限责任公司 一种多肽类物质及其制备方法和用途
FR2836483B1 (fr) * 2002-02-22 2006-09-15 Innate Pharma Procedes de production de lymphocytes gamma delta t
ATE477276T1 (de) 2002-03-01 2010-08-15 Immunomedics Inc Internalisierung von anti cd74 monoklonalen antikörpern und deren verwendungen
EP1556036A2 (en) 2002-09-23 2005-07-27 The Chancellor, Masters And Scholars Of The University Of Oxford Use of iminosugar derivatives to inhibit ion channel activity
EP2364716A3 (en) 2002-11-08 2012-01-11 Genentech, Inc. Compositions and methods for the treatment of natural killer cell related diseases
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
WO2004110349A2 (en) * 2003-05-14 2004-12-23 Siga Technologies, Inc. Sars t cell epitopes and methods for identifying same
JP2007537975A (ja) 2003-06-10 2007-12-27 ザ　ユニバーシティー　オブ　メルボルン 免疫調節性組成物、それらについての使用方法およびそれらの製造のための方法
WO2005007673A2 (en) 2003-07-03 2005-01-27 Rush University Medical Center Immunogenic peptides
US8101714B2 (en) 2004-02-18 2012-01-24 The University Of Georgia Research Foundation, Inc. Teleost derived antimicrobial polypeptides
WO2006114799A1 (en) * 2005-04-27 2006-11-02 Universita' Degli Studi Di Roma 'tor Vergata' Synthetic peptides for the diagnosis and therapy of berillium granulomatous disease
US20080094510A1 (en) * 2005-08-05 2008-04-24 Samsung Electronics Co., Ltd. Apparatus for providing multiple screens and method of dynamically configuring multiple screens
WO2007091240A2 (en) 2006-02-06 2007-08-16 Immune System Key Ltd. Treatment of immunological diseases
US20080095798A1 (en) 2006-10-18 2008-04-24 Robert Humphreys Ii-key enhanced vaccine potency
US20090291884A1 (en) 2006-11-02 2009-11-26 Michael Agadjanyan Proteins for use in diagnosing and treating infection and disease
EP2117558A4 (en) * 2007-01-26 2013-04-03 Univ Colorado METHOD FOR MODULATING THE IMMUNO FUNCTION
EP2215108A4 (en) 2007-10-23 2012-07-04 Univ Colorado COMPETITIVE INHIBITORS OF THE EXPRESSION OF THE CONSTANT CHAIN AND / OR THE ECTOPIC CLIP BINDING
CA2730773A1 (en) * 2008-07-14 2010-01-21 Martha Karen Newell Methods and products for treating proliferative diseases
EP2323681A4 (en) * 2008-07-25 2012-11-14 Univ Colorado METHOD FOR TREATING VIRAL DISEASES
US20100166782A1 (en) * 2008-07-25 2010-07-01 Martha Karen Newell Clip inhibitors and methods of modulating immune function
WO2010011315A2 (en) * 2008-07-25 2010-01-28 Viral Genetics, Inc. Proteins for use in diagnosing and treating infection and disease
WO2012094495A2 (en) 2011-01-05 2012-07-12 The Texas A&M University System Clip modulation for the treatment of mucosal diseases
WO2012138708A1 (en) * 2011-04-04 2012-10-11 The Texas A&M University System Mhc engagement and clip modulation for the treatment of disease
CA2862491A1 (en) * 2011-12-01 2013-06-06 Scott & White Healthcare Methods and products for treating preeclampsia and modulating blood pressure

Similar Documents

Publication Publication Date Title
JP2011502964A5 (OSRAM)
JP2018171063A5 (OSRAM)
JP2014520120A5 (OSRAM)
JP2012525844A5 (OSRAM)
JP2004536077A5 (OSRAM)
JP2006506942A5 (OSRAM)
JP2018515101A5 (OSRAM)
JP2008508859A5 (OSRAM)
WO2003087768A3 (en) Targets for therapeutic intervention identified in the mitochondrial proteome
JP2008536483A5 (OSRAM)
JP2002514205A (ja) 修飾型ポリアミドによる、主溝ｄｎａ結合タンパク質の阻害
AU2017311698B2 (en) Formulations for oral administration of active agents
JP2019533722A5 (OSRAM)
JP2011518179A5 (OSRAM)
JP2010530238A5 (OSRAM)
JP2010536714A5 (OSRAM)
JP2007535910A5 (OSRAM)
WO2002020561A1 (en) Novel polypeptides and anti-hiv drugs containing the same
JP2008521795A5 (OSRAM)
JP2012518669A5 (OSRAM)
JP2008541776A5 (OSRAM)
JP2008517998A5 (OSRAM)
JP2003522185A5 (OSRAM)
JP2016539911A5 (OSRAM)
JP2019038772A5 (OSRAM)